# ORIC Pharmaceuticals funding: rounds and investors > ORIC Pharmaceuticals has raised $248M across 4 rounds since 2014. Investors include Foresite Capital, Invus and ArrowMark Partners. Every round with its source. Source: https://millionrounds.com/company/oric-pharmaceuticals (Millionrounds; every figure on the page links to its filing or article) United States · [Funded startup](https://millionrounds.com/companies) # Who invested in *ORIC Pharmaceuticals* 4 rounds we have observed, with the 13 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it. Biotech Healthcare Pharma Funding summary Updated 26 Oct 2026 **$248M** raised across 4 rounds since 2014, from 4 sources **$15M** Series A **$53M** Series B **$55M** Series D **$125M** Round - **Latest round:** Round, $125M May 2025 - **Step-up i:** 2.3× - **Investors:** 13 (2 led) See who backed them ## The funding story Each circle is a round, placed by date and sized by amount. The line above is the running total. 2016 2018 2020 2022 2024 **$15M** Series A **$53M** Series B **$55M** Series D **$125M** Round - **First round:** Series A, $15M - **Biggest round:** $125M - **Usual gap between rounds:** 3.7 years ## The rounds - **May 2025** Round **$125M** *3 new* *1 returning* [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [SR One](https://millionrounds.com/fund/sr-one) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) Source recorded SEC filing: $125M sold, first sale May 2025 - **Aug 2019** Series D **$55M** *4 new* [Invus](https://millionrounds.com/fund/invus) Lead [ArrowMark Partners](https://millionrounds.com/fund/arrowmark-partners) Lead [Casdin Capital](https://millionrounds.com/fund/casdin-capital) [Hartford HealthCare Endowment](https://millionrounds.com/fund/hartford-healthcare-endowment) Reported by Pharmanewsdaily - **Dec 2015** Series B **$53M** *6 new* [OrbiMed](https://millionrounds.com/fund/orbimed) [Foresite Capital](https://millionrounds.com/fund/forsite-capital) [The Column Group](https://millionrounds.com/fund/the-column-group) [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) [Topspin Partners](https://millionrounds.com/fund/topspin-partners) Kravis Investment Partners From a historical funding record - **Nov 2014** Series A **$15M** No investor was named in the report. From a historical funding record ## Founders and team From ORIC Pharmaceuticals's own website: 5 on the team. - **Dan Iazzetti** Vice President, Head of People - **Dominic Piscitelli** Chief Financial Officer - **Matthew Panuwat** Chief Business Officer - **Mardi C. Dier** Board Member - **Steve L. Hoerter** Board Member ## Who was in which round The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led. **Series A** 2014 **Series B** 2015 **Series D** 2019 **Round** 2025 [Foresite Capital](https://millionrounds.com/fund/forsite-capital) [Invus](https://millionrounds.com/fund/invus) L [ArrowMark Partners](https://millionrounds.com/fund/arrowmark-partners) L [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) [OrbiMed](https://millionrounds.com/fund/orbimed) [Vivo Capital](https://millionrounds.com/fund/vivo-capital) [SR One](https://millionrounds.com/fund/sr-one) [Casdin Capital](https://millionrounds.com/fund/casdin-capital) [The Column Group](https://millionrounds.com/fund/the-column-group) [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) ## Everyone who backed them [Foresite Capital](https://millionrounds.com/fund/forsite-capital) Private equity **2** rounds [Invus](https://millionrounds.com/fund/invus) Private equity **1** round, led 1 [ArrowMark Partners](https://millionrounds.com/fund/arrowmark-partners) Private equity **1** round, led 1 [New Enterprise Associates](https://millionrounds.com/fund/new-enterprise-associates) VC firm **1** round [OrbiMed](https://millionrounds.com/fund/orbimed) Private equity **1** round [Vivo Capital](https://millionrounds.com/fund/vivo-capital) Private equity **1** round [SR One](https://millionrounds.com/fund/sr-one) Corporate VC **1** round [Casdin Capital](https://millionrounds.com/fund/casdin-capital) VC firm **1** round [The Column Group](https://millionrounds.com/fund/the-column-group) VC firm **1** round [EcoR1 Capital](https://millionrounds.com/fund/ecor1-capital) Private equity **1** round [Topspin Partners](https://millionrounds.com/fund/topspin-partners) VC firm **1** round [Hartford HealthCare Endowment](https://millionrounds.com/fund/hartford-healthcare-endowment) VC firm **1** round Kravis Investment Partners no record of our own yet **1** round Missing a round, or an investor who was in one? [Tell us](https://millionrounds.com/corrections?slug=oric-pharmaceuticals). ## Also claim to have backed them These 4 firms list ORIC Pharmaceuticals as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above. [Nextech Invest](https://millionrounds.com/fund/nextech-invest) Private equity Per its own site [City Hill Ventures](https://millionrounds.com/fund/city-hill-ventures) VC firm 2020, per its site [Taiho Ventures](https://millionrounds.com/fund/taiho-ventures) Corporate VC Per its own site [Paratus Investment](https://millionrounds.com/fund/paratus-investment-inc) Private equity 2018, per its site ## Quick answers about ORIC Pharmaceuticals ### Who invested in ORIC Pharmaceuticals? ORIC Pharmaceuticals's investors include Foresite Capital, Invus, ArrowMark Partners, New Enterprise Associates and OrbiMed, and 8 more on record. ### How much has ORIC Pharmaceuticals raised? ORIC Pharmaceuticals has raised $248M across 4 rounds since 2014. ### When did ORIC Pharmaceuticals last raise? ORIC Pharmaceuticals's most recent round was an Undisclosed round of $125M in May 2025. ### What was ORIC Pharmaceuticals's biggest round? Its most recent round, $125M in May 2025, is also its largest on record. ### Who backed ORIC Pharmaceuticals first? ORIC Pharmaceuticals's first round on record, in Dec 2015, was backed by OrbiMed, Foresite Capital and The Column Group and 3 others. ### What stage is ORIC Pharmaceuticals at? ORIC Pharmaceuticals's latest named round is an Undisclosed round, in May 2025. ### Where is ORIC Pharmaceuticals based? ORIC Pharmaceuticals is based in the United States. ### Who led ORIC Pharmaceuticals's rounds? Invus led the Series D in 2019. ## Companies like ORIC Pharmaceuticals In the same sector, and raised in the last eighteen months. [**Star Therapeutics** $325M · Oct 2026](https://millionrounds.com/company/star-therapeutics)[**Promaxo** $106M · Oct 2026](https://millionrounds.com/company/promaxo)[**Prolific Machines** $105M · Oct 2026](https://millionrounds.com/company/prolific-machines)[**AI** $18M · Oct 2026](https://millionrounds.com/company/ai)[**Baba** $40M · Oct 2026](https://millionrounds.com/company/baba)[**IMIO** $19M · Oct 2026](https://millionrounds.com/company/imio) ## Find investors like these Search every investor by what they have actually funded, then narrow to your stage and market. Free. Open the investor searchOr these rounds in the app